Using xylooligosaccharide lowered OGTT 2 h insulin levels in adults with prediabetes, suggesting that these prebiotics are more beneficial in alleviating the risk factors of T2D than treating it [94]. The gene discussed is INS; the disease is prediabetes syndrome.